Industrial Valle del Cinca S/N Apartado Barbastro, Huesca E-22300 Facility: Avient Corporation - Bethel, CT 19 Francis J Clark Circle Bethel, CT 06801 Activity: Design and Manufacture of Specialty Engineered Thermoplastics Activity: Design and Manufacture of Colorants and Compounds for Fluoropolymer and High Temperature Polymers. Activity: Design and Manufacture of Colorants and Additives for Plastics Page 6 of 10 833 Ridgeview Drive 921 Ridgeview Drive Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Facility: Avient Corporation - Merate, Italy Via Bergamo 51 23807, Merate, Lecco Facility: Avient Corporation - North Baltimore, OH 733 E. Box 9053 Malmö, Skåne SE-200 39 Sweden 831 Ridgeview Drive Activity: Design and Manufacture of Colour and Additive Concentrates, Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Page 7 of 10 Facility: Avient Corporation - Oricain (Pamplona), Spain Pol.

Activity: Design and Manufacture of Colorants and Additives for Plastics Page 6 of 10 833 Ridgeview Drive 921 Ridgeview Drive Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Facility: Avient Corporation - Merate, Italy Via Bergamo 51 23807, Merate, Lecco Facility: Avient Corporation - North Baltimore, OH 733 E. Water Street North Baltimore, OH 45872 Activity: Manufacture of Colour and Additive Concentrates, Thermoplastic Resins and Specialty Compounds Activity: Design and Manufacture of Custom PVC Plastisol and PVC Slush Mold Powder Facility: Avient Corporation - Malmö, Sweden Järnyxegatan 7 P.O. Box 9053 Malmö, Skåne SE-200 39 Sweden 831 Ridgeview Drive Activity: Design and Manufacture of Colour and Additive Concentrates, Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Page 7 of 10 Facility: Avient Corporation - Oricain (Pamplona), Spain Pol.

Industrial Valle del Cinca S/N Apartado Barbastro, Huesca E-22300 Facility: Avient Corporation - Bethel, CT 19 Francis J Clark Circle Bethel, CT 06801 Activity: Design and Manufacture of Specialty Engineered Thermoplastics Activity: Design and Manufacture of Colorants and Compounds for Fluoropolymer and High Temperature Polymers. Activity: Design and Manufacture of Colorants and Additives for Plastics Page 6 of 10 833 Ridgeview Drive 921 Ridgeview Drive Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Facility: Avient Corporation - Merate, Italy Via Bergamo 51 23807, Merate, Lecco Facility: Avient Corporation - North Baltimore, OH 733 E. Box 9053 Malmö, Skåne SE-200 39 Sweden 831 Ridgeview Drive Activity: Design and Manufacture of Colour and Additive Concentrates, Activity: Design, Manufacture and Distribution of Thermoplastic Elastomer Page 7 of 10 Facility: Avient Corporation - Oricain (Pamplona), Spain Pol.

Our facility upgrades and LSS activities continue at an aggressive pace, and our recently upgraded commercial team has been fully deployed in pursuit of new business." At the same time, we continue to allocate capital to provide additional value to shareholders, through dividends and share buybacks, repurchasing 1.5 million shares in the first quarter." We should also see continued progress at DSS as we execute our operational and commercial improvement initiatives."

Smarter Materials™ High Performance Thermoplastics: eBook Learn about high-performance thermoplastics that surpass commodity and engineering resins

Food-Safe TPE: Versaflex™ thermoplastic elastomer (TPE) enables consumer products manufacturers to replace a thermoplastic vulcanizate (TPV) silicone material with a softer, child-friendly TPE material, while maintaining strict compliance with food contact regulations in Japan and China.

Thermoplastics: Trilliant™ HC high performance formulations deliver excellent chemical resistance and durability for medical device enclosures and components. Overmolded thermoplastic elastomers: Versaflex™ HC solutions provide excellent chemical resistance to alcohol, bleach and peroxide based antiseptics, and bonds to chemically resistant substrate resins for superior adhesion and durability across a wide range of applications.

Home // Products // Thermoplastic Elastomers // TPE Knowledge Center // Injection Molding Guide // Injection Molding: Part Design // Injection Molding: Part Design Thermoplastic materials that have different properties in the flow direction versus the cross-flow direction (90° perpendicular to the flow direction) are characterized as "anisotropic" materials.

Home // Products // Thermoplastic Elastomers // TPE Knowledge Center // Injection Molding Guide // Injection Molding: Part Design // Injection Molding: Part Design Thermoplastic materials that have different properties in the flow direction versus the cross-flow direction (90° perpendicular to the flow direction) are characterized as "anisotropic" materials.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  Our ability to realize anticipated savings and operational benefits from the realignment of assets, including the closure of manufacturing facilities;  The timing of closings and shifts of production to new facilities related to asset realignments and any unforeseen loss of customers and/or disruptions of service or quality caused by such closings and/or production shifts;  Separation and severance amounts that differ from original estimates;  Amounts for non-cash charges related to asset write-offs and accelerated depreciation realignments of property, plant and equipment, that differ from original estimates;  Our ability to identify and evaluate acquisition targets and consummate acquisitions;  The ability to successfully integrate acquired companies into our operations, retain the management teams of acquired companies, retain relationships with customers of acquired companies, and achieve the expected results of such acquisitions, including whether such businesses will be accretive to our earnings;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;  Changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.  The above list of factors is not exhaustive.  We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. PolyOne Corporation Page 4 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2015 2016 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Substantial EPS growth from $0.13 to all-time high of $1.96 • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Specialty mix expands to 65% of Operating Income – strongest mix of earnings in history • Deliver consistent double digit annual EPS growth • Maintain >35% vitality index • Pursue strategic acquisitions that expand specialty offerings and geographic breadth • Invest and grow current and next generation talent PolyOne Corporation Page 5 Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence Associates PolyOne Corporation Page 6 26 Consecutive Quarters of EPS Growth PolyOne Corporation Page 7 2015 Revenues: $3.4 Billion End Markets 2015 Revenues: $3.4 Billion PolyOne At A Glance $0.12 $0.27 $0.21 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Adjusted EPS 66% Building & 10%Electrical & Textiles $1.96 Distribution 29% PP&S CAI 23% SEM 15%DSS PolyOne Corporation Page 8 Old PolyOne *Operating Income excludes corporate charges and special items 43% 65% 0% 40% 80% 2005 2010 2015 2020 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 80%+ Specialty OI $5M $87M $229M Mix Shift Highlights Specialty Transformation Transformation 2020 PolyOne Corporation Page 9 Color and Engineered Materials at the Heart of Specialty Transformation OPERATING MARGIN 1.7% 4.6% 5.1% 5.5% 7.2% 8.1% 12.2% 16.7% 17.0% COLOR, ADDITIVES AND INKS 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% 8.6% 9.3% 12.1% 16.6% SPECIALTY ENGINEERED MATERIALS PolyOne Corporation Page 10 2006 1Q 2016 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income % Specialty: Color, Additives & Inks 1.7% 17.0% 20%+ Specialty Engineered Materials 1.1% 16.6% 20%+ Designed Structures & Solutions N/A 2.5% (TTM) 8 – 10% Performance Products & Solutions 5.5% 11.9% 12 – 14% Distribution 2.6% 6.5% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 61% 80%+ 3) ROIC* 5.0% 12.0% 15% 4) Adjusted EPS Growth N/A 22% Double Digit Expansion Proof of Performance & 2020 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 11 Therma-Tech™ & Sheet GEON™ Vinyl Polymer ColorantsTherma-Tech™ TPE’s & Film TPE + OnForce™ Gravi-Tech™ Page 11 Film Target End Markets… Healthcare PolyOne Corporation Page 12 TPE + OnForce OnForce TPE Vibration Dampening (SEM/GLS) TPE & Film (SEM + DSS) Polymer Colorants (CAI) Thermatech Thermoplastic Elastomers TPE + OnForce OnForce Thermoplastic Elastomers Polymer Colorants (CAI) Sheet (DSS) Source: Outdoor Industry Association Target End Markets… Outdoor High Performance PolyOne Corporation Page 13 Sound & Vibration Management Fuel Handling Systems Interior & Exterior Trim Structural Braces & Brackets Interior Structural Components Lighting Air management Electronics & Cameras Fluid Handling Target End Markets… Automotive Underhood Components Roof Systems PolyOne Corporation Page 14 Target End Markets… Packaging PreservaPak™ OnColor™ Smart Batch™ VersaFlex™ TPE Cap Liner ColorMatrix™ Amosorb™ Oxygen Scavenger ColorMatrix™ Ultimate™ UV Light Barrier OnCap™ Laser Marking Additives PolyOne Corporation Page 15 Innovation Drives Earnings Growth *Specialty Platform revenue from products introduced in last five years $53 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 34% CAI & SEM Gross Margin 43% Target ≥ 35% Innovation Pipeline Potential PolyOne Corporation Page 16 2,883 2,414 Volume (lbs in millions) -16% $103 $192 Commercial, R&D and Marketing Spending ($M) +86% $303 $721 Adjusted Gross Profit ($M) +138% Ours is Not a Cost Cutting Story PolyOne Corporation Page 17 Design and Service as a Differentiator Right Material & Color Desired Product Design Appropriate Manufacturing Process Delivering Concept to Commercialization Connecting the Dots with iQ Design Labs and InVisiO Color Design PolyOne Corporation Page 18 Customer First Through World-Class Service Strengthening relationships through:  Providing LSS services to small/medium sized customers  Providing training in Customer Centric Selling Skills with customers World’s Best Business Process Excellence Program in 2012* World’s Best Start-up program for Lean Six Sigma Deployment in 2009* 81% 93% 16.2% On-Time Delivery Working Capital % of Sales  52% of associates trained in LSS  Five consecutive years – CFO Magazine Best Working Capital Management in the chemical industry Commitment to Operational Excellence PolyOne Corporation Page 19 30% 40% 50% 70% 80% 90% 2008 1Q 2016 Pension Funding** As of March 31, 2016 Debt Maturities & Pension Funding Net Debt / Adjusted EBITDA*= 2.5x ** includes US-qualified pension plans only*TTM 3/31/2016 $550 $600 $200 $300 $400 $500 $600 $700 $800 2022 2023 Debt Maturities As of March 31, 2016 ($ millions) Coupon Rate: 3.750% 5.250% PolyOne Corporation Page 20 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.32 $0.40 $0.48 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 2016 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth  Synergy opportunities  Adjacent material solutions  Repurchased 1.5 million shares in Q1 2016  Repurchased 17.3 million shares since early 2013  10.0 million shares are available for repurchase under the current authorization $0.24 PolyOne Corporation Page 21 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? Adjusted EPS is calculated as follows: Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y 2015Y Net income (loss) attributable to PolyOne common shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 Joint venture equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - - - Special items, after tax(1) (51.2) 10.7 457.2 (75.9) (72.5) (72.8) 36.2 32.6 90.5 28.9 Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5 88.7 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 Adjusted EPS Q1 2009* Q2 2009* Q3 2009* Q4 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 Net income attributable to PolyOne common shareholders $ 3.3 $ 1.3 $ 51.3 $ 50.8 $ 20.1 $ 44.7 $ 0.1 $ 87.6 Joint venture equity earnings, after tax (8.2) (5.8) (3.0) (2.0) (0.5) (4.5) (6.2) (3.5) Special items, after tax(1) (10.2) 9.2 (36.9) (38.0) (3.8) (22.1) 25.4 (72.0) Adjusted net (loss) income $ (15.1) $ 4.7 $ 11.4 $ 10.8 $ 15.8 $ 18.1 $ 19.3 $ 12.1 Diluted shares 92.2 93.5 93.9 94.4 95.3 96.3 96.3 97.4 Adjusted EPS $ (0.16) $ 0.05 $ 0.12 $ 0.11 $ 0.17 $ 0.19 $ 0.20 $ 0.12 Adjusted EPS Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Net income attributable to PolyOne common shareholders $ 106.0 $ 23.1 $ 16.0 $ 8.3 $ 15.3 $ 18.4 $ 19.4 $ 0.2 Joint venture equity earnings, after tax (3.7) - - - - - - - Special items, after tax(1) (81.3) 1.3 2.8 4.4 6.2 8.9 5.4 15.7 Adjusted net income $ 21.0 $ 24.4 $ 18.8 $ 12.7 $ 21.5 $ 27.3 $ 24.8 $ 15.9 Diluted shares 96.4 95.5 94.0 91.9 90.7 90.7 90.2 90.5 Adjusted EPS $ 0.22 $ 0.26 $ 0.20 $ 0.14 $ 0.24 $ 0.30 $ 0.28 $ 0.18 2 Adjusted EPS Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Net income (loss) attributable to PolyOne common shareholders $ 11.2 $ 38.6 $ 23.2 $ 21.0 $ 29.4 $ 30.9 $ 32.3 $ (14.6) Special items, after tax(1) 17.7 (2.0) 12.3 4.6 12.5 17.4 13.1 47.5 Adjusted net income $ 28.9 $ 36.6 $ 35.5 $ 25.6 $ 41.9 $ 48.3 $ 45.4 $ 32.9 Diluted shares 92.8 99.1 98.1 97.2 95.7 94.3 93.1 91.3 Adjusted EPS $ 0.31 $ 0.37 $ 0.36 $ 0.26 $ 0.44 $ 0.51 $ 0.49 $ 0.36 Adjusted EPS Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Net income attributable to PolyOne common shareholders $ 30.2 $ 66.8 $ 44.5 $ 3.1 $ 39.1 Special items, after tax(1) 11.4 (15.9) 3.0 30.4 9.1 Adjusted net income $ 41.6 $ 50.9 $ 47.5 $ 33.5 $ 48.2 Diluted shares 90.1 89.8 88.4 86.6 85.5 Adjusted EPS $ 0.46 $ 0.57 $ 0.54 $ 0.39 $ 0.56 Adjusted operating margin is calculated as follows: Adjusted operating margin Q1 2009* Q2 2009* Q3 2009* Q4 2009* YTD 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 YTD 2010 Operating Income $ 9.9 $ 17.1 $ 57.9 $ 52.2 $ 137.1 $ 32.3 $ 58.6 $ 42.0 $ 26.3 $ 159.2 Special items (1) (1.3) 4.6 (27.5) (24.5) (48.7) - (14.5) 5.5 4.2 (4.8) Joint venture equity earnings (12.8) (9.0) (4.8) (3.1) (29.7) (0.8) (7.1) (9.7) (5.5) (23.1) Adjusted operating (loss) income $ (4.2) $ 12.7 $ 25.6 $ 24.6 $ 58.7 $ 31.5 $ 37.0 $ 37.8 $ 25.0 $ 131.3 Sales $ 463.4 $ 496.5 $ 548.3 $ 552.5 $ 2,060.7 $ 604.0 $ 666.2 $ 650.7 $ 585.3 $ 2,506.2 Operating Margin (0.9)% 2.6% 4.7% 4.5% 2.8% 5.2% 5.6% 5.8% 4.3% 5.2% Adjusted operating margin Q1 2011 Q2 2011 Q3 2011 Q4 2011 YTD 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 YTD 2012 Operating income (loss) $ 173.4 $ 42.4 $ 33.4 $ (46.2) $ 203.0 $ 37.4 $ 43.3 $ 43.5 $ 13.3 $ 137.5 Special items (1) (127.2) 2.7 4.9 72.9 (46.7) 8.5 11.8 8.3 25.3 53.9 Joint venture equity earnings (5.7) - - - (5.7) - - - - - Adjusted operating income $ 40.5 $ 45.1 $ 38.3 $ 26.7 $ 150.6 $ 45.9 $ 55.1 $ 51.8 $ 38.6 $ 191.4 Sales $ 682.8 $ 723.4 $ 694.0 $ 609.2 $ 2,709.4 $ 745.5 $ 756.6 $ 707.7 $ 651.0 $ 2,860.8 Operating Margin 5.9% 6.2% 5.5% 4.4% 5.6% 6.2% 7.3% 7.3% 5.9% 6.7% 3 Adjusted operating margin Q1 2013 Q2 2013 Q3 2013 Q4 2013 YTD 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 YTD 2014 Operating income (loss) $ 40.5 $ 80.7 $ 61.6 $ 48.7 $ 231.5 $ 56.4 $ 49.4 $ 63.6 $ (14.3) $ 155.1 Special items (1) 16.6 (5.2) 10.8 7.8 30.0 22.9 39.8 22.0 80.2 164.9 Adjusted operating income $ 57.1 $ 75.5 $ 72.4 $ 56.5 $ 261.5 $ 79.3 $ 89.2 $ 85.6 $ 65.9 $ 320.0 Sales $ 801.1 $ 1,037.6 $ 1,008.9 $ 923.6 $ 3,771.2 $ 1,002.3 $ 1,005.5 $ 958.4 $ 869.3 $ 3,835.5 Operating Margin 7.1% 7.3% 7.2% 6.1% 6.9% 7.9% 8.9% 8.9% 7.6% 8.3% Adjusted operating margin Q1 2015 Q2 2015 Q3 2015 Q4 2015 YTD 2015 Q1 2016 Operating income $ 70.1 $ 80.3 $ 69.2 $ 31.3 $ 250.9 $ 71.3 Special items (1) 9.3 11.9 18.7 31.4 71.3 13.8 Adjusted operating income $ 79.4 $ 92.2 $ 87.9 $ 62.7 $ 322.2 $ 85.1 Sales $ 873.1 $ 887.1 $ 841.6 $ 775.8 $ 3,377.6 $ 847.0 Operating Margin 9.1% 10.4% 10.4% 8.1% 9.5% 10.0% Adjusted gross margin is calculated as follows: (In millions) Twelve Months Ended December 31, 2015 Gross margin - GAAP $ 681.5 Special items in gross margin(1) 39.7 Gross margin before special items $ 721.2 Specialty operating income mix percentage is calculated as follows: Platform operating income mix percentage 2005* 2010* 2015 Color, Additives and Inks $ 4.3 $ 37.7 $ 135.4 Specialty Engineered Materials 0.4 49.7 79.6 Designed Structures and Solutions - - 13.8 Specialty Platform $ 4.7 $ 87.4 $ 228.8 Performance Products and Solutions 75.7 54.0 57.4 Distribution 19.5 42.0 68.0 Joint ventures 91.9 18.9 — Corporate and eliminations (51.5) (27.7) (103.3) Operating income GAAP $ 140.3 $ 174.6 $ 250.9 Less: Corporate operating expense 51.5 27.7 103.3 Operating income excluding Corporate $ 191.8 $ 202.3 $ 354.2 Specialty platform operating mix percentage 2% 43% 65% 4 Adjusted EBITDA and net debt to adjusted EBITDA is calculated as follows: (In millions) Q2 2015 Q3 2015 Q4 2015 Q1 2016 Trailing Twelve Months Ended March 31, 2016 Income (loss) from continuing operations, before income taxes $ 63.4 $ 51.4 $ (0.4) $ 57.0 $ 171.4 Interest expense, net 16.2 16.2 15.6 14.6 62.6 Depreciation and amortization 25.0 28.3 25.9 27.2 106.4 Special items, impact on income (loss) from continuing operations before income taxes(1) 11.9 18.6 47.8 13.6 91.9 Accelerated depreciation included in special items (0.2) (4.3) (1.6) (2.8) (8.9) Adjusted EBITDA $ 116.3 $ 110.2 $ 87.3 $ 109.6 $ 423.4 Short-term and current portion of long-term debt $ 18.6 Long-term debt 1,174.3 Less: Cash and cash equivalents (155.4) Net Debt 1,037.5 Net Debt/TTM Adjusted EBITDA 2.5 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal, discontinued operations or the related resegmentation